JPH08502948A - カラノライド抗ウイルス性化合物、組成物およびその用途 - Google Patents
カラノライド抗ウイルス性化合物、組成物およびその用途Info
- Publication number
- JPH08502948A JPH08502948A JP5517559A JP51755993A JPH08502948A JP H08502948 A JPH08502948 A JP H08502948A JP 5517559 A JP5517559 A JP 5517559A JP 51755993 A JP51755993 A JP 51755993A JP H08502948 A JPH08502948 A JP H08502948A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- antiviral
- calanolide
- compounds
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. はC1〜C6アルキルまたはアリール)、およびR4およびR5は同一または異なっ からなる群より選択される実質的に純粋な形態の抗ウイルス性カラノライド化合 物またはその抗ウイルス性誘導体。 2. からなる群より選択される実質的に純粋な形態の請求の範囲第1項に記載の抗ウ イルス性カラノライド化合物。 3. はC1〜C6アルキルまたはアリール)、およびR4およびR5は同一または異なっ からなる群より選択される実質的に純粋な形態の請求の範囲第1項に記載の抗ウ イルス性カラノライド誘導体。 4.次の工程からなる、Calophyllum属の植物からカラノライド化合物および その誘導体を単離する方法。 (a)有機溶媒で乾燥植物材料を抽出し、粗抽出物を得て、 (b)該粗抽出物を液−液分配して非極性画分中にカラノライド化合物を濃縮し、 (c)該非極性画分をゲル浸透クロマトグラフィーまたは減圧液体クロマトグラフ ィーに付し、 (d)シリカゲルおよびC18逆相カラム上のHPLCにより該カラノライド化合物 を単離および精製する。 5.該植物材料がCalophyllum lanigerumである請求の範囲第4項記載の方法 。 6.抗ウイルス有効量の請求の範囲第2項記載の少なくとも一つの化合物、お よび医薬的に許容される担体を含有する抗ウイルス性組成物。 7.請求の範囲第2項記載の抗ウイルス性化合物以外の少なくとも一つの併用 抗ウイルス性化合物の抗ウイルス有効量をさらに含有する請求の範囲第6項記載 の組成物。 8.併用抗ウイルス性化合物がAZT、ddI、ddC、ガンシクロビル、フ ッ素化ジデオキシヌクレオチド、ネビラピン、R82913、Ro31−8959 、BI−RJ−70、アシクロビル、α−インターフェロン、および組換えCD 4からなる群より選択される請求の範囲第7項記載の組成物。 9.抗ウイルス有効量の請求の範囲第3項記載の少なくとも一つの化合物、お よび医薬的に許容される担体を含有する抗ウイルス性組成物。 10.請求の範囲第3項記載の抗ウイルス性化合物以外の少なくとも一つの併用 抗ウイルス性化合物の抗ウイルス有効量をさらに含有する請求の範囲第9項記載 の組成物。 11.併用抗ウイルス性化合物がAZT、ddI、ddC、ガンシクロビル、フ ッ素化ジデオキシヌクレオチド、ネビラピン、R82913、Ro31−8959 、BI−RJ−70、アシクロビル、α−インターフェロン、および組換えCD 4からなる群より選択される請求の範囲第10項記載の組成物。 12.抗ウイルス有効量の請求の範囲第2項記載の少なくとも一つの化合物をヒ トに投与することからなるウイルス感染の予防または治療方法。 13.請求の範囲第2項記載の抗ウイルス性化合物以外の少なくとも一つの併用 抗ウイルス性化合物の抗ウイルス有効量をさらに併用投与することからなる請求 の範囲第12項記載の方法。 14.併用抗ウイルス性化合物がAZT、ddI、ddC、ガンシクロビル、フ ッ素化ジデオキシヌクレオチド、ネビラピン、R82913、Ro31−8959 、BI−RJ−70、アシクロビル、α−インターフェロン、および組換えCD 4からなる群より選択される請求の範囲第13項記載の方法。 15.該ウイルス感染がレトロウイルスによるものである請求の範囲第12項記載 の方法。 16.該レトロウイルスがヒト免疫不全ウイルスである請求の範囲第15項記載の 方法。 17.抗ウイルス有効量の請求の範囲第3項記載の少なくとも一つの化合物をヒ トに投与することからなるウイルス感染の予防または治療方法。 18.請求の範囲第3項記載の抗ウイルス性化合物以外の少なくとも一つの併用 抗ウイルス性化合物の抗ウイルス有効量をさらに併用投与することからなる請求 の範囲第17項記載の方法。 19.併用抗ウイルス性化合物がAZT、ddI、ddC、ガンシクロビル、フ ッ素化ジデオキシヌクレオチド、ネビラピン、R82913、Ro31−8959 、BI−RJ−70、アシクロビル、α−インターフェロン、および組換えCD 4からなる群より選択される請求の範囲第18項記載の方法。 20.該ウイルス感染がレトロウイルスによるものである請求の範囲第17項記載 の方法。 21.該レトロウイルスがヒト免疫不全ウイルスである請求の範囲第20項記載の 方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86124992A | 1992-03-31 | 1992-03-31 | |
US861,249 | 1992-03-31 | ||
PCT/US1993/002810 WO1993020082A1 (en) | 1992-03-31 | 1993-03-24 | Calanolide antiviral compounds, compositions and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08502948A true JPH08502948A (ja) | 1996-04-02 |
JP3103114B2 JP3103114B2 (ja) | 2000-10-23 |
Family
ID=25335281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP05517559A Expired - Lifetime JP3103114B2 (ja) | 1992-03-31 | 1993-03-24 | カラノライド抗ウイルス性化合物、組成物およびその用途 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0633887B1 (ja) |
JP (1) | JP3103114B2 (ja) |
AT (1) | ATE180259T1 (ja) |
AU (1) | AU671827B2 (ja) |
CA (1) | CA2133080C (ja) |
DE (1) | DE69325020T2 (ja) |
DK (1) | DK0633887T3 (ja) |
ES (1) | ES2134259T3 (ja) |
GR (1) | GR3030852T3 (ja) |
WO (1) | WO1993020082A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016053059A (ja) * | 2010-09-22 | 2016-04-14 | クラウン リサーチ エスディーエヌ ビーエイチディー | カラノライドの医薬組成物及びその調製方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08505146A (ja) * | 1992-12-23 | 1996-06-04 | スミスクライン・ビーチャム・コーポレイション | レトロウイルス阻害剤としてのクマリン誘導体 |
US5892060A (en) * | 1994-08-03 | 1999-04-06 | Sarawak Medichem Pharmaceuticals, Inc. | Method for the preparation of (+)-calanolide a and analogues thereof |
US5977385A (en) * | 1994-08-03 | 1999-11-02 | Sarawak Medichem Pharmaceuticals | Method for the preparation of (+)-calanolide A and analogues thereof |
US6043271A (en) * | 1994-08-03 | 2000-03-28 | Sarawak Medichem Pharmaceuticals, Inc. | Method for the preparation of (±)-calanolide A and intermediates thereof |
US6277879B1 (en) | 1994-08-03 | 2001-08-21 | Sarawak Medichem Pharmaceuticals, Inc. | Calanolide analogues and methods of their use |
US5608085A (en) * | 1995-02-27 | 1997-03-04 | The University Of Tennessee Research Corporation | Synthesis of optically active calanolides A and B and enantiomers and related compounds |
US6160131A (en) * | 1997-12-19 | 2000-12-12 | Sarawak Medichem Pharmaceuticals, Inc. | Scalable method for the isolation of anti-HIV agents from the tropical plant calophyllum |
CA2346813A1 (en) * | 1998-10-15 | 2000-04-20 | Sarawak Medichem Pharmaceuticals Incorporated | Method and composition for treating and preventing tuberculosis |
WO2000064903A2 (en) | 1999-04-26 | 2000-11-02 | Sarawak Medichem Pharmaceuticals, Inc. | Methods for preparing antiviral calanolide compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5211944A (en) * | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
-
1993
- 1993-03-24 EP EP93908587A patent/EP0633887B1/en not_active Expired - Lifetime
- 1993-03-24 AT AT93908587T patent/ATE180259T1/de active
- 1993-03-24 ES ES93908587T patent/ES2134259T3/es not_active Expired - Lifetime
- 1993-03-24 AU AU39355/93A patent/AU671827B2/en not_active Expired
- 1993-03-24 DK DK93908587T patent/DK0633887T3/da active
- 1993-03-24 CA CA002133080A patent/CA2133080C/en not_active Expired - Lifetime
- 1993-03-24 WO PCT/US1993/002810 patent/WO1993020082A1/en active IP Right Grant
- 1993-03-24 DE DE69325020T patent/DE69325020T2/de not_active Expired - Lifetime
- 1993-03-24 JP JP05517559A patent/JP3103114B2/ja not_active Expired - Lifetime
-
1999
- 1999-07-27 GR GR990401936T patent/GR3030852T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016053059A (ja) * | 2010-09-22 | 2016-04-14 | クラウン リサーチ エスディーエヌ ビーエイチディー | カラノライドの医薬組成物及びその調製方法 |
Also Published As
Publication number | Publication date |
---|---|
AU3935593A (en) | 1993-11-08 |
GR3030852T3 (en) | 1999-11-30 |
CA2133080A1 (en) | 1993-10-14 |
DE69325020T2 (de) | 1999-11-18 |
EP0633887B1 (en) | 1999-05-19 |
JP3103114B2 (ja) | 2000-10-23 |
EP0633887A1 (en) | 1995-01-18 |
DE69325020D1 (de) | 1999-06-24 |
WO1993020082A1 (en) | 1993-10-14 |
CA2133080C (en) | 2006-06-06 |
ATE180259T1 (de) | 1999-06-15 |
ES2134259T3 (es) | 1999-10-01 |
DK0633887T3 (da) | 1999-11-29 |
AU671827B2 (en) | 1996-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2852706B2 (ja) | カラノライドおよび関連抗ウイルス性化合物、組成物、およびそれらの用途 | |
EP0775130B1 (en) | Method for the preparation of (+/-)-calanolide a and intermediates thereof | |
US5723631A (en) | Coumarin derivatives as retroviral inhibitors | |
US20080020068A1 (en) | Use Of Trisubstituted Benzopyranones | |
AU707798B2 (en) | Biflavanoids and derivatives thereof as antiviral agents | |
JPH08502948A (ja) | カラノライド抗ウイルス性化合物、組成物およびその用途 | |
JP2922648B2 (ja) | 抗ウイルス性ナフトキノン化合物、その組成物および用途 | |
KR100187881B1 (ko) | 데커시놀 안젤레이트를 유효성분으로 하는 항암제 | |
US6043271A (en) | Method for the preparation of (±)-calanolide A and intermediates thereof | |
US5079239A (en) | Sterol disulfates and methods of use | |
US5892060A (en) | Method for the preparation of (+)-calanolide a and analogues thereof | |
US6277879B1 (en) | Calanolide analogues and methods of their use | |
US5977385A (en) | Method for the preparation of (+)-calanolide A and analogues thereof | |
US6774141B1 (en) | Calanolide and related antiviral compounds, compositions, and uses thereof | |
AU685468C (en) | Calanolide and related antiviral compounds, compositions, and uses thereof | |
Guchait et al. | A review on reported phytochemicals as druggable leads with antimalarial potential | |
JP2006321728A (ja) | 新規な抗リーシュマニア医薬組成物 | |
AU3588199A (en) | Method for the preparation of (+-)-calanolide A and intermediates thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080825 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080825 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080825 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080825 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090825 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090825 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090825 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090825 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090825 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100825 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100825 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100825 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100825 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100825 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110825 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110825 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110825 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110825 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110825 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120825 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120825 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120825 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120825 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120825 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130825 Year of fee payment: 13 |